A new therapeutic target for myelofibrosis is cause for Gli
- PMID: 28566426
- PMCID: PMC5546312
- DOI: 10.1126/scitranslmed.aan4297
A new therapeutic target for myelofibrosis is cause for Gli
Abstract
Myeloproliferative neoplasm cells recruit Gli1 positive mesenchymal stromal cells to transdifferentiate into fibrosis-causing myofibroblasts, a process that can be inhibited by a Gli inhibitor.
Copyright © 2017, American Association for the Advancement of Science.
Comment on
-
Gli1+ Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target.Cell Stem Cell. 2017 Jun 1;20(6):785-800.e8. doi: 10.1016/j.stem.2017.03.008. Epub 2017 Apr 27. Cell Stem Cell. 2017. PMID: 28457748 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources